CRISPR-Cas9-producing probiotic bacteria for editing NOX2/gp91phox and treating inflammatory bowel disease
Chen Zhang, Tianyu Li, Huoye Hao, Gang Wang, Yuzhe Zhang, Yue Huang, Lili Chen, Jin Wang, Xiang-Jiao Yang, Xiuli Bi · 2026
Read CRISPR-Cas9-producing probiotic bacteria for editing NOX2/gp91phox and treating inflammatory bowel disease by Chen Zhang, Tianyu Li, Huoye Hao, Gang Wang, Yuzhe Zhang, Yue Huang, Lili Chen, Jin Wang, Xiang-Jiao Yang, Xiuli Bi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13522793.txt.
Description
Chen Zhang and colleagues engineer a probiotic bacterium to deliver gene editing into the gut in a 2026 study of inflammatory bowel disease. The disease involves excess reactive oxygen species, unstable molecules that damage the intestinal barrier. A harmless gut bacterium was equipped with CRISPR editing tools aimed at a gene that helps produce those reactive molecules, then wrapped in a protective gel for oral delivery.
The gel raised bacterial survival sharply in tests. In immune cells, the system cut the target gene's expression by nearly half and reduced reactive molecules by most of their level. In mice with induced colitis, oral treatment eased inflammation and activated protective pathways that boosted antioxidant defenses. The authors present the living delivery system as a promising strategy for bowel inflammation.
Catalog record
| CREATOR | Chen Zhang, Tianyu Li, Huoye Hao, Gang Wang, Yuzhe Zhang, Yue Huang, Lili Chen, Jin Wang, Xiang-Jiao Yang, Xiuli Bi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 59542 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |